Pharmaceutical Composition Comprising a Benzoheterocyclic Compound and Androgen Receptor Pathway Modulator and Application Thereof
AssigneeKangpu Biopharmaceuticals, Ltd.
InventorsChuansheng GE, Baisong LIAO, Wen-Cherng LEE
Life of this patent
Estimating the term…
Abstract
Disclosed are a pharmaceutical composition comprising a benzoheterocyclic compound and androgen receptor pathway modulator and an application thereof. The pharmaceutical composition includes one or more of a benzoheterocyclic compound, a pharmaceutically acceptable salt thereof, a solvate thereof, a crystalline form thereof, a co-crystal thereof, a stereoisomer thereof, an isotope compound thereof, a metabolite thereof and a pro-drug thereof, and an androgen receptor pathway modulator. The pharmaceutical composition better inhibits prostate cancer cell growth.
Claims15
A pharmaceutical composition, comprising one selected from the group consisting of a benzoheterocyclic compound or a pharmaceutically acceptable salt thereof, and an androgen receptor pathway modulator;
- wherein the benzoheterocyclic compound is selected from the group consisting of:
- the androgen receptor pathway modulator is selected from the group consisting of Enzalutamide, ARN-509, ODM-201, Galeterone, Abiraterone acetate, Enzualutamide and ARN-509, Enzalutamide and Galeterone, Galeterone and Abiraterone acetate, Enzalutamide and Abiraterone acetate, Enzalutamide and Abiraterone, Enzalutamide and ODM-201, ARN-509 and Galeterone, ARN-509 and Abiraterone acetate, ARN-509 and Abiraterone, ARN-509 and ODM-201, ODM-201 and Galeterone, ODM-201 and Abiraterone acetate, and ODM-201 and Abiraterone.
Dependencies are inferred from the claim text.